ISR insider filings

Perspective Therapeutics, Inc. — 43 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-04-19. Screen ISR transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ISR between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Perspective Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2023-04-194Woods Lori A — DirectorOption exercise (M): 163,934 @ $0.61 · Option exercise (M): 23,566 @ $0.61 · Option exercise (M): 163,934 (derivative) @ $0 · Option exercise (M): 23,566 (derivative) @ $0EDGAR
2023-03-174Williamson Robert F III — DirectorGrant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-02-234Morich Frank — DirectorGrant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-02-234Woods Lori A — DirectorGrant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR
2023-02-234McCormick Michael W — DirectorGrant/award (A): 470,000 (derivative) @ $0 · Grant/award (A): 230,000 (derivative) @ $0EDGAR
2022-12-054Hunt Jonathan Robert — Chief Financial OfficerPurchase (P): 53,204 @ $0.38 · Purchase (P): 32,200 @ $0.38EDGAR
2022-11-174Woods Lori A — CEO, DirectorPurchase (P): 100,000 @ $0.34EDGAR
2022-09-224/AStreeter Jennifer — COO & VP of HROption exercise (M): 50,000 @ $0.43 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-08-194Streeter Jennifer — COO & VP of HROption exercise (M): 50,000 @ $0.43 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2022-08-114Austin Mark John — VP Finance/Prin Fin&Acct OfficGrant/award (A): 150,000 (derivative) @ $0EDGAR
2022-08-104Streeter Jennifer — COO & VP of HROption exercise (M): 22,500 @ $0.33 · Option exercise (M): 22,500 (derivative) @ $0EDGAR
2022-08-014Cavanagh William — Chief R&D OfficerGrant/award (A): 475,000 (derivative) @ $0EDGAR
2022-07-294McCormick Michael W — DirectorGrant/award (A): 135,000 (derivative) @ $0EDGAR
2022-07-284Streeter Jennifer — COO & VP of HRGrant/award (A): 475,000 (derivative) @ $0EDGAR
2022-07-284Hoffmann Alan — DirectorGrant/award (A): 135,000 (derivative) @ $0EDGAR
2022-07-284Vitale Philip J — DirectorGrant/award (A): 135,000 (derivative) @ $0EDGAR
2022-07-284Woods Lori A — CEO, DirectorGrant/award (A): 940,000 (derivative) @ $0EDGAR
2022-07-284Hunt Jonathan Robert — Chief Financial OfficerGrant/award (A): 475,000 (derivative) @ $0EDGAR
2022-06-094Austin Mark John — VP Finance/Prin Fin&Acct OfficPurchase (P): 5,000 @ $0.28 · Purchase (P): 13,800 @ $0.29EDGAR
2022-06-094Woods Lori A — CEO, DirectorPurchase (P): 75,000 @ $0.30EDGAR
2022-06-094Hunt Jonathan Robert — Chief Financial OfficerPurchase (P): 13,325 @ $0.28 · Purchase (P): 25,675 @ $0.29EDGAR
2022-02-174MOHR MARSHALL — see RemarksOption exercise (M): 2,124 @ $0 · Tax withholding (F): 749 @ $289.31 · Option exercise (M): 1,749 @ $0 · Tax withholding (F): 668 @ $289.31 · Option exercise (M): 2,124 (derivative) @ $0 · Option exercise (M): 1,749 (derivative) @ $0EDGAR
2021-11-244Woods Lori A — CEO, DirectorOption exercise (M): 62,500 @ $0.46 · Option exercise (M): 62,500 @ $0.43 · Option exercise (M): 62,500 (derivative) @ $0 · Option exercise (M): 62,500 (derivative) @ $0EDGAR
2021-10-264MOHR MARSHALL — Executive VP & CFOOption exercise (M): 20,475 @ $59.23 · Sale (S): 20,475 @ $339.20 · Option exercise (M): 20,475 (derivative) @ $0EDGAR
2021-07-064Austin Mark John — Controller/Prin Fin&Acct OfficGrant/award (A): 133,500 (derivative) @ $0EDGAR
2021-07-064Streeter Jennifer — COO & VP of HRGrant/award (A): 320,000 (derivative) @ $0EDGAR
2021-07-064Hoffmann Alan — DirectorGrant/award (A): 135,000 (derivative) @ $0EDGAR
2021-07-064Vitale Philip J — DirectorGrant/award (A): 135,000 (derivative) @ $0EDGAR
2021-07-064Cavanagh William — Chief R&D OfficerGrant/award (A): 320,000 (derivative) @ $0EDGAR
2021-07-064Woods Lori A — CEO, DirectorGrant/award (A): 480,000 (derivative) @ $0EDGAR
2021-07-064Hunt Jonathan Robert — Chief Financial OfficerGrant/award (A): 320,000 (derivative) @ $0EDGAR
2021-07-064McCormick Michael W — DirectorGrant/award (A): 135,000 (derivative) @ $0EDGAR
2021-03-164Woods Lori A — CEO, DirectorOption exercise (M): 25,000 @ $0.60 · Option exercise (M): 62,500 @ $0.46 · Option exercise (M): 62,500 @ $0.43 · Option exercise (M): 62,500 @ $0.61 · Option exercise/expiry (X): 24,038 @ $0.57 · Option exercise (M): 25,000 (derivative) @ $0 · +4 moreEDGAR
2021-03-024MOHR MARSHALL — Executive VP & CFOOption exercise (M): 752 @ $0 · Tax withholding (F): 373 @ $0 · Grant/award (A): 3,421 (derivative) @ $0 · Grant/award (A): 2,281 (derivative) @ $0 · Option exercise (M): 752 (derivative) @ $0EDGAR
2020-12-024Woods Lori A — CEO, DirectorPurchase (P): 68,000 @ $0.38EDGAR
2020-10-284Austin Mark John — Controller/Prin Fin&Acct OfficPurchase (P): 19,230 @ $0.52 · Purchase (P): 9,615 (derivative) @ $0EDGAR
2020-10-284Krachon Michael — EVP of Sales & MarketingPurchase (P): 28,844 @ $0.52 · Purchase (P): 14,422 (derivative) @ $0EDGAR
2020-10-284Hoffmann Alan — DirectorPurchase (P): 19,230 @ $0.52 · Purchase (P): 9,615 (derivative) @ $0EDGAR
2020-10-284Vitale Philip J — DirectorPurchase (P): 20,000 @ $0.52 · Purchase (P): 10,000 (derivative) @ $0EDGAR
2020-10-284Cavanagh William — Chief R&D OfficerPurchase (P): 7,692 @ $0.52 · Purchase (P): 3,846 (derivative) @ $0EDGAR
2020-10-284Woods Lori A — CEO, DirectorPurchase (P): 48,076 @ $0.52 · Purchase (P): 24,038 (derivative) @ $0EDGAR
2020-10-284Hunt Jonathan Robert — Chief Financial OfficerPurchase (P): 67,306 @ $0.52 · Purchase (P): 33,653 (derivative) @ $0EDGAR
2020-10-284McCormick Michael W — DirectorPurchase (P): 19,230 @ $0.52 · Purchase (P): 9,615 (derivative) @ $0EDGAR

Recent 8-K events — Perspective Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-098-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-208-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-018-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-088-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ISR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs